Takeda Pharmaceutical (4502.T) Revenue Growth

Price: $4540
Market Cap: $7.20T
Avg Volume: 4.11M
Country: JP
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 0.414
52W Range: $3852-4573
Website: Takeda Pharmaceutical

What is Takeda Pharmaceutical's Revenue Growth?

  • Takeda Pharmaceutical's annual revenue growth as of FY 2023 is 5.87%.
  • Takeda Pharmaceutical's quarterly revenue growth as of Q3 2024 is -2.71%.

What is Revenue Growth?

Revenue growth is the increase in a company's sales over a specific period. It's a crucial metric for evaluating a company's financial health and its ability to expand its market presence and generate higher sales.

Related Metrics

Other important metrics to assess Takeda Pharmaceutical's financial performance include:

  • Revenue - the total revenue generated by a company:
    • Annual: $4.26T
    • Quarterly: $1.14T
  • Cost of Revenue - the total cost of producing the goods or services sold by a company:
    • Annual: $1.43T
    • Quarterly: $416.87B
  • Cost of Revenue Growth - the rate at which a company's cost of revenue is growing:
    • Annual Growth: 15.07%
    • Quarterly Growth: -22.33%
  • Gross Profit - the difference between revenue and the cost of revenue:
    • Annual: $2.83T
    • Quarterly: $727.25B
  • Gross Profit Growth - the rate at which a company's gross profit is growing:
    • Annual Growth: 1.76%
    • Quarterly Growth: 13.75%

These metrics provide insights into Takeda Pharmaceutical's financial health and its ability to generate revenue efficiently. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Revenue Growth

5.87%

Quarterly Revenue Growth

-2.71%

Historical Annual Revenue Growth
56.93%56.93%44.71%44.71%32.49%32.49%20.27%20.27%8.05%8.05%-4.17%-4.17%Revenue Growth (Annual)201620162017201720182018201920192020202020212021202220222023202320242024
Historical Quarterly Revenue Growth
14.95%14.95%9.40%9.40%3.85%3.85%-1.70%-1.70%-7.25%-7.25%-12.80%-12.80%Revenue Growth (Quarterly)20232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Historical Annual Revenue
$5.00T$5.00T$4.00T$4.00T$3.00T$3.00T$2.00T$2.00T$1.00T$1.00T$0.00$0.00Revenue (Annual)201620162017201720182018201920192020202020212021202220222023202320242024
Historical Quarterly Revenue
$1.50T$1.50T$1.20T$1.20T$900.00B$900.00B$600.00B$600.00B$300.00B$300.00B$0.00$0.00Revenue (Quarterly)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Annual Cost of Revenue
$1.60T$1.60T$1.20T$1.20T$800.00B$800.00B$400.00B$400.00B$0.00$0.00Cost of Revenue (Annual)201620162017201720182018201920192020202020212021202220222023202320242024
Historical Quarterly Cost of Revenue
$600.00B$600.00B$500.00B$500.00B$400.00B$400.00B$300.00B$300.00B$200.00B$200.00B$100.00B$100.00B$0.00$0.00Cost of Revenue (Quarterly)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Annual Gross Profit
$3.50T$3.50T$2.80T$2.80T$2.10T$2.10T$1.40T$1.40T$700.00B$700.00B$0.00$0.00Gross Profit (Annual)201620162017201720182018201920192020202020212021202220222023202320242024
Historical Quarterly Gross Profit
$800.00B$800.00B$600.00B$600.00B$400.00B$400.00B$200.00B$200.00B$0.00$0.00Gross Profit (Quarterly)20162016201720172018201820192019202020202021202120222022202320232024202420252025

Takeda Pharmaceutical Historical Revenue Growth Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Revenue Revenue Growth Cost of Revenue Cost of Revenue Growth Gross Profit Gross Profit Growth
2024 $4.26T 5.87% $1.43T 15.07% $2.83T 1.76%
2023 $4.03T 12.85% $1.24T 12.40% $2.78T 13.05%
2022 $3.57T 11.61% $1.11T 11.32% $2.46T 11.74%
2021 $3.20T -2.84% $994.31B -8.76% $2.20T 0.09%
2020 $3.29T 56.93% $1.09T 65.19% $2.20T 53.14%
2019 $2.10T 18.45% $659.69B 33.02% $1.44T 12.78%
2018 $1.77T 2.22% $495.92B -11.25% $1.27T 8.63%
2017 $1.73T -4.17% $558.75B 4.36% $1.17T -7.76%
2016 $1.81T 1.66% $535.40B 2.77% $1.27T 1.20%
2015 $1.78T 5.09% $520.99B 6.27% $1.26T 4.61%

Related Metrics

Explore detailed financial metrics and analysis for 4502.T.